Silvia Capriello

Silvia Capriello

Auto-generated profile, based on publicly available information

Silvia Capriello

Endocrinology Unit, Santa Maria Goretti Hospital, Latina, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Open access
PDF file
CVCamilla Virili
Camilla Virili
ISIlaria Stramazzo
Ilaria Stramazzo
MBMaria Flavia Bagaglini
Maria Flavia Bagaglini
ACAnna Lucia Carretti
Anna Lucia Carretti
SCSilvia Capriello
Silvia Capriello
MCMarco Centanni
Marco Centanni
In recent years, a growing number of studies have examined the relationship between thyroid pathophysiology and intestinal microbiota composition. The reciprocal influence between these two entities has been proven so extensive that some authors coined the term "gut-thyroid axis". However, since some papers reported conflicting results, several aspects of this correlation need to be clarified. This systematic review was conceived to achieve more robust information about: 1)the characteristics of gut microbiota composition in patients with the more common morphological, functional and autoimmune disorders of the thyroid; 2)the influence of gut microbial composition on micronutrients that are essential for the maintenance of thyroid homeostasis; 3)the effect of probiotics, prebiotics and synbiotics, some of the most popular over-the-counter products, on thyroid balance; 4)the opportunity to use specific dietary advice. The literature evaluation was made by three authors independently. A five steps strategy was a priori adopted. After duplicates removal, 1106 records were initially found and 38 reviews were finally included in the analysis. The systematic reviews of reviews found that: 1) some significant variations characterize the gut microbiota composition in patients with thyroid disorders. However, geographical clustering of most of the studies prevents drawing definitive conclusions on this topic; 2) the available knowledge about the effect of probiotics and synbiotics are not strong enough to suggest the routine use of these compounds in patients with thyroid disorders; 3) specific elimination nutrition should not be routine suggested to patients, which, instead have to be checked for possible micronutrients and vitamins deficiency, often owed to gastrointestinal autoimmune comorbidities.

2 September 2022 in Endocrine Abstracts
Verified
Journal Article
Closed access
CVCamilla Virili
Camilla Virili
Simone FilardoSimone Filardo
Simone Filardo
ISIlaria Stramazzo
Ilaria Stramazzo
SCSilvia Capriello
Silvia Capriello
SGSantaguida Maria Giulia
Santaguida Maria Giulia
MCMarco Centanni
Marco Centanni
Objectives: Variations of gut microbiota composition have been described in patients with different thyroid disorders. The site of oral levothyroxine (T4) absorption is represented by the small intestine and it has been demonstrated that some bacterial strains possess enzymatic activity that may affect iodothyronine deconjugation, process probably involved in thyroid hormone enterohepatic recycling. The relationship between gut microflora composition and oral T4 requirement has, as yet, not been analyzed, and represents the aim of the present study. Patients and Methods: Twenty two hypothyroid adult patients (19F/3M) treated with oral levothyroxine at a stable dose for at least two years, have been subdivided into two groups on the basis of their T4 requirement: A) group, showing an increased need for T4 (10 patients; 9F/1M; median dose 1.76 mg/kg/day) or a normal one, B) group (12 patients; 10F/2M; median dose 1.36 mg/kg/day). All patients had TSH values between 0.8 and 2 mU/l. All patients took T4 in fasting state, avoiding all food and drugs interfering with T4 absorption and action. Moreover, none of included patients followed unbalanced diets, had disorders, or used drugs, interfering with faecal microbial composition. From each patient faecal samples were provided. Microbiota composition was determined via 16s rDNA sequencing of the hypervariable region V3-4 on Illumina MiSeq. Alpha and beta-diversity indices and all statistical analysis were computed in Qiime2. Results: Alpha-diversity indices showed an increased relative abundance of Firmicutes in BEN group while an increased relative abundance of Bacteroidetes and Proteobacteria characterized MAL group. Beta-diversity analysis, revealed a significant difference between the microbial populations of patients belonging to the two groups through weighted UniFrac analysis (P = 0.008). The ANalysis of COmposition of Microbiomes (ANCOM) between the different taxonomic units revealed that Bacteriodetes phylum is significantly associated to the increased need for T4, while Firmicutes phylum is associated to a normal T4 absorption. The Linear discriminant analysis with Effect Size measurement (LEfSe) allowed the identification of potential biomarkers associated to the increased need for T4, mostly belonging to the class of beta-Proteobacteria. Conclusions: Despite the low number of patients, typical of a pilot study, this is the first characterization of faecal microbiota composition of hypothyroid patients with the specific focus on T4 requirement.